The Impact of Immersive Virtual Reality Training in Thyroid Surgery

Last updated: April 9, 2025
Sponsor: G.Gennimatas General Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Convetional Training

Virtual Reality Training in Thyroid Surgery

Clinical Study ID

NCT06917755
17010/2910-2024
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Up to this date, there have been no reports on virtual reality (VR) training in thyroid surgery. The purpose of this study is to determine the impact of VR training in residents' education.

Investigators intend to include general surgery residents in the trial, subgrouped in a VR training group and another one with traditional learning, utilizing a technical textbook as a control. For the purpose of this study, a commercial available VR mask will be given for training in the VR group. Randomization will be used to secure balance in the distribution of residents according to their experience. The task which will be examined include surgical steps from neck incision up to the placement of the C-IONM electrode and will be evaluated by a blinded FEBS certified endocrine surgeon in the operating theatre.

Training superiority will be assessed by the outcome measures of Objective Structured Assessment of Technical Skills (OSATS) score, need for the main surgeon to intervene (NTI), verbal answers and time to task completion. Participants will complete questionnaires regarding satisfaction of the whole educational process.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Residents of the 2nd Surgical Department of Aristotle University of Thessaloniki

  • Residents who have completed their 1st year of training programm.

Exclusion

Exclusion Criteria:

  • Disagreement of participants' randomisation

  • Prolonged surgical time of completion

  • Participant's experience beyond the included limits

  • Participants who are completely incapable of using VR devices or have specifichelath restrictions of using these

  • Patients with complex thyroid disease such as recurrent disease, concominant primaryhyperparathyroidism, lymph node disease or metastasis, Graves disease andintrathoracic goiter

Study Design

Total Participants: 12
Treatment Group(s): 2
Primary Treatment: Convetional Training
Phase:
Study Start date:
February 20, 2025
Estimated Completion Date:
May 30, 2025

Connect with a study center

  • "Georgios Gennimatas" General Hospital of Thessaloniki

    Thessaloniki, 54635
    Greece

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.